ENTRY       D11805                      Drug
NAME        Cetuximab sarotalocan sodium (genetical recombination) (JAN);
            Akalux (TN)
REMARK      Therapeutic category: 4299
            Product: D11805<JP>
EFFICACY    Antineoplastic
  TYPE      Antibody-drug conjugate
COMMENT     Antibody-photosensitizer conjugate
TARGET      EGFR [HSA:1956] [KO:K04361]
  PATHWAY   hsa04010(1956)  MAPK signaling pathway
            hsa04012(1956)  ErbB signaling pathway
            hsa05200(1956)  Pathways in cancer
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4299  Others
                 D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR
                 D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN) &lt;JP&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11805
DBLINKS     PubChem: 405226671
///
